SCHEMBL1069159

SCHEMBL1069159

CCCCOC(=O)CCc1ccc(Cl)c(N)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 2/20 0.46
ALDH1A1 P00352 4/20 0.45
TDP1 Q9NUW8 3/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
P2RY10 O00398 1/20 0.42
GLA P06280 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
ESR1 P03372 1/20 0.42
HSD17B10 Q99714 1/20 0.42
CYP4F2 P78329 1/20 0.41
CYP4A11 Q02928 1/20 0.41
EPHX2 P34913 2/20 0.41
DGKA P23743 1/20 0.41
LMNA P02545 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
TSHR P16473 1/20 0.40
CYP2C19 P33261 1/20 0.40
PDE4D Q08499 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12723403 0.86 CYP4F2 (0.56) APPALDH1A1TDP1SMN1; SMN2CYP4F2
SCHEMBL19737385 0.85 APP (0.57) APPALDH1A1TDP1P2RY10ESR1
SCHEMBL23019185 0.83 APP (0.57) APPALDH1A1TDP1P2RY10HSD17B10
SCHEMBL1903256 0.81 ALDH1A1 (0.43) APPALDH1A1TDP1P2RY10HSD17B10
SCHEMBL10900609 0.80 LMNA (0.58) APPALDH1A1TDP1L3MBTL1P2RY10
SCHEMBL28968060 0.80 TDP1 (0.53) ALDH1A1TDP1L3MBTL1P2RY10SMN1; SMN2
SCHEMBL1905900 0.80 ALDH1A1 (0.49) ALDH1A1L3MBTL1TSHR
SCHEMBL584536 0.79 APP (0.43) APPALDH1A1TDP1L3MBTL1GLA
SCHEMBL18843960 0.77 TDP1 (0.56) APPALDH1A1TDP1L3MBTL1P2RY10
SCHEMBL1905729 0.77 NPC1 (0.41) APPALDH1A1SMN1; SMN2CYP4F2CYP4A11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2268625-A1 OXO-HETEROCYCLIC SUBSTITUTED CARBOXYLIC ACID DERIVATES AND THE USE THEREOF Bayer Schering Pharma Aktiengesellschaft (DE) 2011-01-05 EP disclosed
WO-2009127338-A1 OXO-HETEROCYCLIC SUBSTITUTED CARBOXYLIC ACID DERIVATES AND THE USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-10-22 WO disclosed